Gimv N.V.

Only nine other biotechs have raised over $25 million since 2015

Plus: Maslowski to become CEO of Forge as Miller steps down, and updates from Sofinnova Partners, Abingworth, PATH and more

Plus: Chiesi elevates next generation, Lang now Lyell’s CBO and updates from OrbiMed, Gimv, Nkarta, InflaRx, Akamis and more

Prevailing market conditions have prompted mindset changes. European biotech valuations may still need to come down

Investment firm ‘spins out’ life sciences VC activity into new platform, giving it its own P&L 

SVB Leerink hired Andrew Fineberg as managing director to lead the firm’s new structured finance group. Fineberg joins from MTS Health Partners, where he served as partner and head of royalty